DK1235573T3 - Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme - Google Patents

Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme

Info

Publication number
DK1235573T3
DK1235573T3 DK00985315T DK00985315T DK1235573T3 DK 1235573 T3 DK1235573 T3 DK 1235573T3 DK 00985315 T DK00985315 T DK 00985315T DK 00985315 T DK00985315 T DK 00985315T DK 1235573 T3 DK1235573 T3 DK 1235573T3
Authority
DK
Denmark
Prior art keywords
riluzole
gabapentin
combination
motor neuron
drug
Prior art date
Application number
DK00985315T
Other languages
Danish (da)
English (en)
Inventor
Andrees Bohme
Christopher Henderson
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1235573T3 publication Critical patent/DK1235573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK00985315T 1999-11-24 2000-11-24 Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme DK1235573T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914765A FR2801217B1 (fr) 1999-11-24 1999-11-24 Association de riluzole et de gabapentine et son utilisation comme medicament
PCT/FR2000/003272 WO2001037832A2 (fr) 1999-11-24 2000-11-24 Association de riluzole et de gabapentine et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
DK1235573T3 true DK1235573T3 (da) 2003-11-24

Family

ID=9552471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985315T DK1235573T3 (da) 1999-11-24 2000-11-24 Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme

Country Status (10)

Country Link
EP (1) EP1235573B1 (de)
JP (1) JP4928697B2 (de)
AT (1) ATE245421T1 (de)
AU (1) AU2177401A (de)
DE (1) DE60004093T2 (de)
DK (1) DK1235573T3 (de)
ES (1) ES2198369T3 (de)
FR (1) FR2801217B1 (de)
PT (1) PT1235573E (de)
WO (1) WO2001037832A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
JP6340366B2 (ja) 2012-07-31 2018-06-06 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 運動ニューロン疾患を診断および処置する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage

Also Published As

Publication number Publication date
AU2177401A (en) 2001-06-04
ES2198369T3 (es) 2004-02-01
FR2801217A1 (fr) 2001-05-25
FR2801217B1 (fr) 2002-12-06
ATE245421T1 (de) 2003-08-15
DE60004093D1 (de) 2003-08-28
WO2001037832A2 (fr) 2001-05-31
JP2003514858A (ja) 2003-04-22
EP1235573A2 (de) 2002-09-04
EP1235573B1 (de) 2003-07-23
PT1235573E (pt) 2003-11-28
WO2001037832A3 (fr) 2002-03-21
DE60004093T2 (de) 2004-06-03
JP4928697B2 (ja) 2012-05-09

Similar Documents

Publication Publication Date Title
PT2336184E (pt) Administração de agentes para o tratamento da inflamação
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
GB0108592D0 (en) Therapeutic agents
CY1106733T1 (el) Αγωγη νευρολογικης δυσλειτουργιας περιλαμβανουσα σουλφαμικες φρουκτοπυρανοζες και ερυθροποιητινη
AR021535A1 (es) Formas de dosificacion de liberacion controlada que comprenden zolpidem o sales del mismo
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
BRPI0408491A (pt) tratamento da doença de alzheimer
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
PT1150704E (pt) Melagatran para o tratamento da inflamacao
HK1046089A1 (zh) 褪黑激素的治疗用途
DK1235573T3 (da) Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
PT1362590E (pt) Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
NO20012777L (no) Anvendelse av riluzol ved behandling av akustiske traumer
MXPA04001268A (es) Inhibidor de anhidrasa carbonica.
NO20042586L (no) Behandlingsfremgangsmate
NO983947D0 (no) Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
FR2807944B1 (fr) Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament